Massive global registry tracks Real-World outcomes for rare kidney disease
NCT ID NCT01522183
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This observational study follows 3,000 people with atypical hemolytic-uremic syndrome (aHUS), a rare and serious kidney condition. Researchers will collect safety and effectiveness data on patients treated with eculizumab or ravulizumab, as well as those receiving other care. The goal is to better understand long-term outcomes and complications of the disease and its treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATYPICAL HEMOLYTIC UREMIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Clinical Trial Site
RECRUITINGAurora, Colorado, 80045, United States
-
Clinical Trial Site
RECRUITINGWashington D.C., District of Columbia, 20007, United States
-
Clinical Trial Site
RECRUITINGGainesville, Florida, 32610, United States
-
Clinical Trial Site
RECRUITINGAtlanta, Georgia, 30322, United States
-
Clinical Trial Site
WITHDRAWNChicago, Illinois, 60614, United States
-
Clinical Trial Site
RECRUITINGBoston, Massachusetts, 02115, United States
-
Clinical Trial Site
RECRUITINGSt Louis, Missouri, 63110, United States
-
Clinical Trial Site
WITHDRAWNWinston-Salem, North Carolina, 27103, United States
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGColumbus, Ohio, 43210, United States
-
Clinical Trial Site
RECRUITINGCairns, Queensland, 4870, Australia
-
Clinical Trial Site
RECRUITINGHerston, Queensland, 4029, Australia
-
Clinical Trial Site
RECRUITINGWoolloongabba, Queensland, 4102, Australia
-
Clinical Trial Site
RECRUITINGAdelaide, South Australia, 5000, Australia
-
Clinical Trial Site
RECRUITINGHeidelberg, Victoria, 3084, Australia
-
Clinical Trial Site
RECRUITINGParkville, Victoria, 3050, Australia
-
Clinical Trial Site
RECRUITINGParkville, Victoria, 3052, Australia
-
Clinical Trial Site
RECRUITINGMurdoch, Western Australia, 6961, Australia
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGNedlands, Western Australia, 6109, Australia
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGBrussels, 1020, Belgium
-
Clinical Trial Site
RECRUITINGBrussels, 1070, Belgium
-
Clinical Trial Site
RECRUITINGBrussels, 1090, Belgium
-
Clinical Trial Site
RECRUITINGLondon, Ontario, N6A 5W9, Canada
-
Clinical Trial Site
RECRUITINGToronto, Ontario, M5G 1X8, Canada
-
Clinical Trial Site
RECRUITINGMontreal, Quebec, H3T 1C5, Canada
-
Clinical Trial Site
RECRUITINGQuébec, Quebec, 44035, Canada
-
Clinical Trial Site
RECRUITINGOdense, 5000, Denmark
-
Clinical Trial Site
RECRUITINGAngers, 49933, France
-
Clinical Trial Site
RECRUITINGBayonne, 64109, France
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGBordeaux, 33076, France
-
Clinical Trial Site
RECRUITINGBrest, 29609, France
-
Clinical Trial Site
RECRUITINGBron, 69677, France
-
Clinical Trial Site
RECRUITINGCaen, 30001, France
-
Clinical Trial Site
RECRUITINGChambéry, 73011, France
-
Clinical Trial Site
RECRUITINGClermont-Ferrand, 63000, France
-
Clinical Trial Site
RECRUITINGDijon, 21080, France
-
Clinical Trial Site
RECRUITINGGrenoble, 38043, France
-
Clinical Trial Site
RECRUITINGLe Kremlin-Bicêtre, 94270, France
-
Clinical Trial Site
RECRUITINGLille, 59037, France
-
Clinical Trial Site
WITHDRAWNLille, France
-
Clinical Trial Site
RECRUITINGLyon, France
-
Clinical Trial Site
RECRUITINGMarseille, France
-
Clinical Trial Site
RECRUITINGMontpellier, France
-
Clinical Trial Site
RECRUITINGNancy, 54500, France
-
Clinical Trial Site
RECRUITINGNantes, 44 093, France
-
Clinical Trial Site
RECRUITINGNice, 51069, France
-
Clinical Trial Site
RECRUITINGPerpignan, France
-
Clinical Trial Site
RECRUITINGPoitiers, France
-
Clinical Trial Site
RECRUITINGPontoise, France
-
Clinical Trial Site
RECRUITINGRennes, 35203, France
-
Clinical Trial Site
RECRUITINGRennes, France
-
Clinical Trial Site
RECRUITINGToulouse, 31059, France
-
Clinical Trial Site
RECRUITINGToulouse, 70034, France
-
Clinical Trial Site
RECRUITINGTours, France
-
Clinical Trial Site
RECRUITINGValenciennes, 50479, France
-
Clinical Trial Site
RECRUITINGEssen, 45147, Germany
-
Clinical Trial Site
RECRUITINGHeidelberg, 69120, Germany
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGLübeck, 23538, Germany
-
Clinical Trial Site
RECRUITINGMünster, 48149, Germany
-
Clinical Trial Site
WITHDRAWNTübingen, 72076, Germany
-
Clinical Trial Site
RECRUITINGBeersheba, 84101, Israel
-
Clinical Trial Site
RECRUITINGFlorence, 50134, Italy
-
Clinical Trial Site
RECRUITINGGenova, 16147, Italy
-
Clinical Trial Site
RECRUITINGMilan, 20163, Italy
-
Clinical Trial Site
RECRUITINGRoma, 00165, Italy
-
Clinical Trial Site
WITHDRAWNTorino, Italy
-
Clinical Trial Site
RECRUITINGLodz, 92-213, Poland
-
Clinical Trial Site
RECRUITINGLodz, 93-338, Poland
-
Clinical Trial Site
COMPLETEDSaint Petersburg, Russia
-
Clinical Trial Site
RECRUITINGDongan, Chungcheongnam-do, 31151, South Korea
-
Clinical Trial Site
RECRUITINGSeoul, Dongnam-ro, 05278, South Korea
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGAnyang-si, Gyeonggi-do, 14068, South Korea
-
Clinical Trial Site
WITHDRAWNGoyang-si, Gyeonggi-do, 411-706, South Korea
-
Clinical Trial Site
RECRUITINGDaegu, Hyeonchung-ro, 42415, South Korea
-
Clinical Trial Site
RECRUITINGGwangju, Jebong Ro, 61469, South Korea
-
Clinical Trial Site
RECRUITINGDaegu, 35015, South Korea
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGJeju-do, 63241, South Korea
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGJeollabuk-do, 54907, South Korea
-
Clinical Trial Site
RECRUITINGPamplona, 15-31008, Spain
-
Clinical Trial Site
WITHDRAWNSeville, 01-41013, Spain
-
Clinical Trial Site
TERMINATEDBasel, 4031, Switzerland
-
Clinical Trial Site
TERMINATEDBern, 3010, Switzerland
-
Clinical Trial Site
TERMINATEDSurich, 8091, Switzerland
-
Clinical Trial Site
RECRUITINGKaohsiung City, 81362, Taiwan
-
Clinical Trial Site
RECRUITINGNew Taipei City, 10002, Taiwan
-
Clinical Trial Site
RECRUITINGTaichung, 40447, Taiwan
-
Clinical Trial Site
RECRUITINGTaoyuan, 33305, Taiwan
-
Clinical Trial Site
RECRUITINGAnkara, 06500, Turkey (Türkiye)
-
Clinical Trial Site
RECRUITINGIstanbul, 34093, Turkey (Türkiye)
-
Clinical Trial Site
RECRUITINGKayseri, 38039, Turkey (Türkiye)
-
Clinical Trial Site
RECRUITINGCardiff, C14 4XW, United Kingdom
-
Clinical Trial Site
RECRUITINGExeter, EX2 5DW, United Kingdom
-
Clinical Trial Site
RECRUITINGLondon, NW3 2PF, United Kingdom
-
Clinical Trial Site
RECRUITINGLondon, W1T 4EU, United Kingdom
-
Clinical Trial Site
RECRUITINGLondon, WC1N 3JH, United Kingdom
-
Clinical Trial Site
RECRUITINGManchester, M13 9WL, United Kingdom
-
Clinical Trial Site
WITHDRAWNNewcastle, NE7 7DN, United Kingdom
-
Clinical Trial Site
RECRUITINGSouthampton, SO16 6YD, United Kingdom
-
Clinical Trial Site
RECRUITINGWales, SA6 6NL, United Kingdom
-
Clinical Trial Site (Adult)
RECRUITINGEdegem, 2650, Belgium
-
Clinical Trial Site (Adult)
RECRUITINGLeuven, 3000, Belgium
-
Clinical Trial Site (Adult)
RECRUITINGLiège, 4000, Belgium
-
Clinical Trial Site (Pediatric)
RECRUITINGEdegem, 2650, Belgium
-
Clinical Trial Site (Pediatric)
RECRUITINGWoluwe-Saint-Lambert, 1200, Belgium
-
Clinical Trial Site (adult)
RECRUITINGWoluwe-Saint-Lambert, 1200, Belgium
-
Clinical Trial Site (pediatric)
RECRUITINGGhent, 9000, Belgium
-
Clinical Trial Site (pediatric)
RECRUITINGLeuven, 3000, Belgium
-
Clinical Trial Site (pediatric)
RECRUITINGLiège, 4000, Belgium
-
Clinical Trial Site 1
RECRUITINGWestmead, New South Wales, 2145, Australia
-
Clinical Trial Site 1
RECRUITINGAmiens, 80054, France
-
Clinical Trial Site 1
RECRUITINGNancy, 54500, France
-
Clinical Trial Site 1
RECRUITINGNantes, 44000, France
-
Clinical Trial Site 1
RECRUITINGParis, 75019, France
-
Clinical Trial Site 1
RECRUITINGRouen, France
-
Clinical Trial Site 1
RECRUITINGStrasbourg, France
-
Clinical Trial Site 1
RECRUITINGHanover, 30625, Germany
-
Clinical Trial Site 1
RECRUITINGBari, 70124, Italy
-
Clinical Trial Site 1
RECRUITINGMilan, 20122, Italy
-
Clinical Trial Site 1
COMPLETEDMoscow, Russia
-
Clinical Trial Site 1
ACTIVE_NOT_RECRUITINGGyeonggi-do, 13620, South Korea
-
Clinical Trial Site 1
RECRUITINGSeoul, South Korea
-
Clinical Trial Site 1
RECRUITINGBarcelona, 09-08035, Spain
-
Clinical Trial Site 2
RECRUITINGWestmead, New South Wales, 2145, Australia
-
Clinical Trial Site 2
RECRUITINGAmiens, 80054, France
-
Clinical Trial Site 2
RECRUITINGParis, 75015, France
-
Clinical Trial Site 2
RECRUITINGRouen, France
-
Clinical Trial Site 2
RECRUITINGStrasbourg, France
-
Clinical Trial Site 2
RECRUITINGHanover, 30625, Germany
-
Clinical Trial Site 2
RECRUITINGBari, 70124, Italy
-
Clinical Trial Site 2
RECRUITINGMilan, 20122, Italy
-
Clinical Trial Site 2
COMPLETEDMoscow, Russia
-
Clinical Trial Site 2
RECRUITINGGyeonggi-do, 46371, South Korea
-
Clinical Trial Site 2
RECRUITINGSeoul, 02841, South Korea
-
Clinical Trial Site 2
RECRUITINGBarcelona, 09-08035, Spain
-
Clinical Trial Site 3
RECRUITINGParis, 75970, France
-
Clinical Trial Site 3
RECRUITINGSeoul, 03722, South Korea
-
Clinical Trial Site 4
RECRUITINGParis, 75015, France
-
Clinical Trial Site 4
RECRUITINGSeoul, 08308, South Korea
-
Clinical Trial Site 5
RECRUITINGParis, 75743, France
-
Clinical Trial Site 5
RECRUITINGSeoul, 05505, South Korea
-
Clinical Trial Site 6
RECRUITINGSeoul, 06351, South Korea
-
Clinical Trial Site 7
RECRUITINGSeoul, 07985, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hope for aHUS patients: Long-Term iptacopan study launches
- Skin biopsies could unlock hidden genetic diagnoses
- Real-World study tracks Ravulizumab's impact on rare kidney disease
- New pill shows promise for rare blood disorder aHUS
- New drug ravulizumab aims to control rare blood disorder aHUS
- Promising aHUS drug trial stalls after only 6 patients enrolled